Anja Ehrhardt - Search Results

Year	Number of Results
2002	3
2003	5
2004	1
2005	1
2006	1
2007	3
2008	3
2009	3
2010	3
2011	5
2012	6
2013	4
2014	2
2015	6
2016	7
2017	8
2018	10
2019	4
2020	12
2021	12
2022	6

1

Episomal vectors for gene therapy.

Ehrhardt A, Haase R, Schepers A, Deutsch MJ, Lipps HJ, Baiker A. Ehrhardt A, et al. Curr Gene Ther. 2008 Jun;8(3):147-61. doi: 10.2174/156652308784746440. Curr Gene Ther. 2008. PMID: 18537590 Review.

2

Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.

Aurnhammer C, Haase M, Muether N, Hausl M, Rauschhuber C, Huber I, Nitschko H, Busch U, Sing A, Ehrhardt A, Baiker A. Aurnhammer C, et al. Among authors: ehrhardt a. Hum Gene Ther Methods. 2012 Feb;23(1):18-28. doi: 10.1089/hgtb.2011.034. Hum Gene Ther Methods. 2012. PMID: 22428977

3

State-of-the-art human adenovirus vectorology for therapeutic approaches.

Gao J, Mese K, Bunz O, Ehrhardt A. Gao J, et al. Among authors: ehrhardt a. FEBS Lett. 2019 Dec;593(24):3609-3622. doi: 10.1002/1873-3468.13691. Epub 2019 Dec 9. FEBS Lett. 2019. PMID: 31758807 Free article. Review.

4

KIR3DS1 directs NK cell-mediated protection against human adenovirus infections.

Jung JM, Ching W, Baumdick ME, Hofmann-Sieber H, Bosse JB, Koyro T, Möller KJ, Wegner L, Niehrs A, Russu K, Ohms M, Zhang W, Ehrhardt A, Duisters K, Spierings E, Hölzemer A, Körner C, Jansen SA, Peine S, Königs I, Lütgehetmann M, Perez D, Reinshagen K, Lindemans CA, Altfeld M, Belderbos M, Dobner T, Bunders MJ. Jung JM, et al. Among authors: ehrhardt a. Sci Immunol. 2021 Sep 17;6(63):eabe2942. doi: 10.1126/sciimmunol.abe2942. Epub 2021 Sep 17. Sci Immunol. 2021. PMID: 34533978

5

Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase.

Weber L, Hagemann A, Kaltenhäuser J, Besser M, Rockenfeller P, Ehrhardt A, Stuermer E, Bachmann HS. Weber L, et al. Among authors: ehrhardt a. Front Microbiol. 2021 Nov 30;12:628283. doi: 10.3389/fmicb.2021.628283. eCollection 2021. Front Microbiol. 2021. PMID: 34917041 Free PMC article.

6

Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy.

Gao J, Zhang W, Ehrhardt A. Gao J, et al. Among authors: ehrhardt a. Cancers (Basel). 2020 May 2;12(5):1139. doi: 10.3390/cancers12051139. Cancers (Basel). 2020. PMID: 32370135 Free PMC article. Review.

7

Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors.

Ehrke-Schulz E, Zhang W, Gao J, Ehrhardt A. Ehrke-Schulz E, et al. Among authors: ehrhardt a. Hum Gene Ther. 2017 Oct;28(10):833-841. doi: 10.1089/hum.2017.140. Hum Gene Ther. 2017. PMID: 28854818 Review.

8

Handling S/MAR vectors.

Hagedorn C, Baiker A, Postberg J, Ehrhardt A, Lipps HJ. Hagedorn C, et al. Among authors: ehrhardt a. Cold Spring Harb Protoc. 2012 Jun 1;2012(6):657-63. doi: 10.1101/pdb.top068262. Cold Spring Harb Protoc. 2012. PMID: 22661441

9

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.

Nettelbeck DM, Leber MF, Altomonte J, Angelova A, Beil J, Berchtold S, Delic M, Eberle J, Ehrhardt A, Engeland CE, Fechner H, Geletneky K, Goepfert K, Holm PS, Kochanek S, Kreppel F, Krutzke L, Kühnel F, Lang KS, Marchini A, Moehler M, Mühlebach MD, Naumann U, Nawroth R, Nüesch J, Rommelaere J, Lauer UM, Ungerechts G. Nettelbeck DM, et al. Among authors: ehrhardt a. Viruses. 2021 Jul 21;13(8):1420. doi: 10.3390/v13081420. Viruses. 2021. PMID: 34452286 Free PMC article. Review.

10

Viral hybrid-vectors for delivery of autonomous replicons.

Zhang W, Hagedorn C, Schulz E, Lipps HJ, Ehrhardt A. Zhang W, et al. Among authors: ehrhardt a. Curr Gene Ther. 2014 Feb;14(1):10-23. doi: 10.2174/1566523213666131223130024. Curr Gene Ther. 2014. PMID: 24365145 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results